tuberculosis

May 12, 2022

Roche, Global Fund Partner to Support Diagnostic Infrastructure in LMICs

Apr 28, 2022

Molecular TB Assay From PBD Biotech Shows Promise in Detecting Latent-to-Active Disease Risk
Premium

Apr 8, 2022

FIND Project Aims to Accelerate Targeted NGS Solutions for Global Drug-Resistant TB Testing
Premium

Feb 7, 2022

Qiagen Next-Gen QuantiFeron Tuberculosis Test Gains Chinese Regulatory Approval

Nov 29, 2021

Qiagen, DiaSorin Obtain FDA Approval for Latent TB Test on Benchtop Platform

Nov 3, 2021

Oxford Immunotec Draws on PerkinElmer Capabilities to Automate Latent TB Test
Premium

Oct 20, 2021

Qiagen Obtains CE Mark for Point-of-Care Tuberculosis Infection Test

Aug 20, 2021

BioMérieux Targeting Hospital Laboratories With Desktop Latent TB Test
Premium

Jul 9, 2021

WHO Updates Recommendations to Improve Access to Rapid MDx Tests for TB, Drug-Resistant TB

May 27, 2021

Dx Firm NanoPin Prepping TB Test for Late 2021 Launch
Premium

May 5, 2021

TB-Focused R2D2 Network Will Support Development of Rapid, Next-Generation Diagnostics
Premium

Mar 23, 2021

BioMérieux Interferon Gamma Release Assay for Latent TB Gets CE Mark

Mar 17, 2021

WHO Updates Recommendations for Point-of-Care Testing for Children, Monitoring of HIV Treatment

Mar 16, 2021

Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing
Premium

Feb 18, 2021

WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance

Jan 7, 2021

PerkinElmer to Buy Oxford Immunotec for $591M

Dec 15, 2020

Imperial College London, Moredun Research Developing Silicon-Based Test for Infectious Disease Screening

Dec 9, 2020

Sequencing-Based Tuberculosis Drug Resistance Testing Gaining Momentum
Premium

Nov 5, 2020

Oxford Immunotec Files FDA Submission for TB Test Sample Prep Kit

Nov 3, 2020

Oxford Immunotec Q3 Revenues Fall 8 Percent on COVID-19 Testing Volumes